Oral Session 2-8A Viral Infection

[OS2-8A-1] Hepatitis B virus (HBV) reactivation in ATL patients with resolved HBV infection after mogamulizumab

Haruhito Totani¹, Shigeru Kusumoto¹, Kentaro Yonekura², Nobuaki Nakano³, Asahi Ito¹, Ilseung Choi⁴, Yoshitaka Imaizumi⁵, Makoto Yoshimitsu⁶, Kisato Nosaka⁷, Michihiro Hidaka⁸, Tatsuro Jo⁹, Hidenori Sasaki¹⁰, Yukiyoshi Moriuchi¹¹, Yoko Suehiro⁴, Ryuzo Ueda¹², Atae Utsunomiya³, Takashi Ishida¹ (1.Dept. Hematol & Oncol., Nagoya City Univ., Nagoya, Japan, 2.Dept. Dermatol., Imamura General Hosp., Kagoshima, Japan, 3.Dept. Hematol., Imamura General Hosp., Kagoshima, Japan, 4.Dept. Hematol., Kyushu Cancer Ctr. Hosp., Fukuoka, Japan, 5.Dept. Hematol., Nagasaki Univ. Hosp., 6.Dept. Hematol & Immunol., Kagoshima Univ. Hosp., Kagoshima, Japan, 7.Dept. Hematol., Kumamoto Univ Hosp., Kumamoto, Japan, 8.Dept. Hematol&Inst. for Clin. Res., Kumamoto Med Ctr., Kumamoto, Japan, 9.Dept. Hematol., Jpn Red Cross Nagasaki Genbaku Hosp., Nagasaki, Japan, 10.Div. Med Oncol, Hematol&Infect Diseases, Fukuoka Univ Hosp., Fukuoka, Japan, 11.Dept. Hematol., Sasebo City General Hosp., Sasebo, Japan, 12.Dept. Tumor Immunol., Aichi Med Univ., Nagakute, Japan)